Evidence-Based Integrative Therapies in Breast Cancer
Clinician education on the topic of integrative therapies can help patients be informed enough to make the best decisions regarding non-conventional and conventional therapies to optimize their oncologic outcomes and quality of life.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Management of Bone Health in Patients with Cancer
The management of long-term bone health for patients with cancer requires a broad knowledge and full understanding of the complementary benefits of available agents along with potential limitations. Although the risk/benefit ratio is usually markedly in favor of treatment, clinicians should be aware of potential adverse effects from these agents used in preventing bone loss, including patient populations deriving benefit, timing, scheduling of therapy, and specific clinical benefits.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Clinical Updates: Primary Therapy of Multiple Myeloma
It is important to help clinicians to keep up-to-date with the newer treatment options available to help select the most efficient treatment strategy. In addition, knowledge of the relevant side effects of the novel drugs reported in pivotal clinical studies and strategies for their prevention and management is also equally important to improve overall patient outcomes.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Kidney Cancer
For patients with advanced RCC, several factors are taken into consideration to help determine which systemic regimen to consider in the first-line and subsequent line therapy. It is important for clinicians to understand when to use regimens for their patient’s unique clinical situation and how to treatment for patients with metastatic RCC requiring second, third, fourth, or further lines of therapy.
Category
  • Kidney Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date October 16, 2019
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Endometrial Cancer
Minimally invasive surgical techniques for endometrial cancers, particularly robotic-assisted laparoscopy, have been shown to decrease surgical morbidity and improve 30-day postoperative outcomes for appropriately selected patients with endometrial cancer. Despite evidence of improved outcomes, disparities persist in awareness of and access to minimally invasive surgery.
Category
  • Women's Health Cancers
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date October 21, 2019
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer
Triple-negative breast cancer is an aggressive subtype that is associated with poor outcomes. Staying up-to-date on current and emerging treatment options is important to integrate new evidence-based data into their clinical practice and optimize patient outcomes.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
NCCN Guidelines® Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer
Immunotherapy recommendations for patients with non-small cell lung cancer (NSCLC) are rapidly changing, and health care providers need to be aware of the most current recommendations in the NCCN Guidelines to improve outcomes for their patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Oncology Case Manager and Medical Director Program™ Live Webinars
Cancer management is complex and the standard of care evolves at a rapid rate.
Category
Format
Credits
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019
Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants.
Category
  • Colorectal Cancer
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Colorectal Cancer
Personalizing treatment selection for each patient with localized colon cancer or metastatic colorectal cancer (mCRC) can maximize the benefits while minimizing the harms to give each patient the best survival and quality of life possible. Clinicians must be knowledgeable about new trial results, new systemic therapy options, new biomarkers, and other treatment-selection criteria in order to help patients make the best informed decisions possible.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages